COMMUNIQUÉS West-GlobeNewswire

Aligos Therapeutics Appoints David Perry as Vice President of Business Development

01/10/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]

BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress

01/10/2024 - 14:00

SAN DIEGO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the [...]

Alignment Health Plan Introduces 2025 Medicare Advantage Plans to Address Diverse Care Needs of Seniors, from Cost Concerns to Chronic Conditions

01/10/2024 - 14:00

Medicare beneficiaries encouraged to evaluate their plan benefits during annual enrollment period, Oct. 15-Dec. 7 ORANGE, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Alignment Health Plan , an award-winning Medicare [...]

Stryker completes acquisition of Vertos Medical, Inc., expanding interventional pain management solutions

01/10/2024 - 14:00

Portage, Michigan, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the acquisition of Vertos Medical Inc., a leader in interventional pain management solutions for chronic [...]

IN8bio Announces Pricing of $12.4 Million Private Placement

01/10/2024 - 14:00

Cash position now expected to fund current operating plan into 2026 Financing provides cash runway to advance the ongoing expansion cohorts in the Phase 1 trial of INB-100 for patients with Acute Myeloid Leukemia (AML) [...]

Barinthus Bio Completes Enrollment for Phase 2b HBV003 Clinical Trial in Chronic Hepatitis B and Phase 1 PCA001 Clinical Trial in Prostate Cancer

01/10/2024 - 14:00

Investigational immunotherapy, VTP-300, is being evaluated as part of a potential functional cure regimen for chronic Hepatitis B. Interim data update for HBV003 anticipated in Q4 2024. Data update for PCA001 [...]

Canadian Dermatology Association (CDA) Announces 2025 Shade Structure Grant Recipients

01/10/2024 - 14:00

OTTAWA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association is proud to announce the recipients of the 2025 CDA Shade Structure Grant Program. This year's grants, aimed at helping public schools, [...]

L’Association canadienne de dermatologie (ACD) annonce les bénéficiaires de ses Subventions pour structures ombrières de 2025

01/10/2024 - 14:00

OTTAWA, 01 oct. 2024 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie est fière d’annoncer les bénéficiaires du Programme de subvention de structures ombrières de l’ACD pour 2025. Cette année, ces [...]

Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development

01/10/2024 - 14:00

CONSHOHOCKEN, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH)/metabolic [...]

Replimune to Present at Two Upcoming Investor Conferences

01/10/2024 - 14:00

WOBURN, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members [...]

BioVie Receives Notice of Allowance for United States Patent Application Covering Novel Liquid Formulation of Terlipressin

01/10/2024 - 14:00

Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India and Chile, and are pending in nine additional markets Formulation has demonstrated room-temperature stability for up to [...]

AssistRx Named a Winner of the Orlando Sentinel Media Group’s Central Florida Top Workplaces 2024 Award

01/10/2024 - 14:00

Healthcare technology and patient solutions provider recognized as a Central Florida top employer for fourth consecutive year ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- AssistRx , the advanced therapy initiation [...]

Amarin Announces Two Upcoming Investor Events

01/10/2024 - 14:00

-- Company to Report Third Quarter 2024 Financial Results Wednesday, October 30 –- -- Amarin to Hold Virtual Analyst & Investor Day Thursday, November 14 -- DUBLIN and BRIDGEWATER, N.J., Oct. 01, 2024 (GLOBE [...]

Transpire Bio Achieves Important Corporate Milestone with Dosing of First Human Subject in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program

01/10/2024 - 14:00

WESTON, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled medicines, today announced the company dosed the first human subject [...]

Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes

01/10/2024 - 14:00

Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial uses VALENCIA, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming [...]

NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis

01/10/2024 - 14:00

– Life DisRPted is an educational campaign aimed at promoting early diagnosis and treatment of recurrent pericarditis, a painful and debilitating chronic autoinflammatory disease – LONDON, Oct. 01, 2024 (GLOBE NEWSWIRE [...]

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

01/10/2024 - 14:00

Ten Military Veteran Volunteers Participated in the Pilot Study Enabled by Athena GTX Health Monitoring System JACKSON CENTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) released the [...]

Precision Optics Corporation to Participate in Lytham Partners Fall 2024 Investor Conference Today

01/10/2024 - 14:00

GARDNER, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]

Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics

01/10/2024 - 14:00

SYDNEY and NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced the [...]